Shoest acting skeletal muscle relaxant is?
The shortest-acting ones are usually the depolarizing type. Succinylcholine comes to mind because it's known for its rapid onset and short duration. It works by binding to nicotinic receptors at the neuromuscular junction, causing depolarization and then desensitization. But wait, are there others with even shorter duration? Maybe some non-depolarizing agents like mivacurium? No, mivacurium is intermediate-acting. Rocuronium is intermediate, and vecuronium is longer. Pancuronium is another non-depolarizing, longer acting. So Succinylcholine is definitely the shortest.
The options probably include other agents. Let's say the options are A: Succinylcholine, B: Pancuronium, C: Vecuronium, D: Rocuronium. Then the correct answer is A. But the user hasn't provided the options. Wait, the user provided the question as "Shoest acting skeletal muscle relaxant is?" with options A-D but left them blank. The correct answer given is [Letter]. [Answer Text]. So I need to fill in the options and the correct answer.
Assuming the options are common muscle relaxants. The correct answer is Succinylcholine. Now, the core concept is about the classification and duration of action of neuromuscular blocking agents. Succinylcholine is a depolarizing agent with a short duration due to rapid hydrolysis by plasma cholinesterase. The other options are non-depolarizing, longer acting. The clinical pearl is that Succinylcholine is used for rapid sequence intubation. Need to make sure the explanation covers why the others are wrong. Each wrong option's duration and mechanism.
**Core Concept**
Short-acting skeletal muscle relaxants are classified as depolarizing or non-depolarizing agents. Succinylcholine, a depolarizing agent, has the shortest duration due to rapid metabolism by plasma cholinesterase, making it ideal for rapid sequence intubation. Non-depolarizing agents like rocuronium or vecuronium have longer durations and require reversal agents.
**Why the Correct Answer is Right**
Succinylcholine (Option A) acts by binding to nicotinic acetylcholine receptors at the neuromuscular junction, causing depolarization followed by desensitization. It is hydrolyzed within 5–10 minutes by pseudocholinesterase, resulting in a brief duration of action (~5–10 minutes). This rapid onset and offset distinguish it from non-depolarizing agents, which block acetylcholine binding without mimicking it. Its use is limited to short procedures or intubation due to risks like hyperkalemia and malignant hyperthermia.
**Why Each Wrong Option is Incorrect**
**Option B: Pancuronium** – A non-depolarizing, intermediate-acting blocker with a duration of 60–90 minutes.
**Option C: Vecuronium** –